Aspen Aerogels (ASPN) Misses Q3 EPS by 5c

Aspen Aerogels (: ASPN) reported Q3 EPS of ($0.11), $0.05 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $31.5 million versus the consensus estimate of $30.85 million.

Adjusted EBITDA for the third quarter of 2015 was $1.7 million, compared to $1.2 million in the third quarter of 2014.

For earnings history and earnings-related data on Aspen Aerogels (ASPN) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c
• Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c